OBJECTIVES: To assess the association between insulinlike growth factor (IGF)-1 and IGF binding protein (IGFBP)-1 with three cognitive function tests in a healthy elderly population. DESIGN: Cross-sectional analyses from the Rancho Bernardo Cohort Study. SETTING: Southern California community of Rancho Bernardo. PARTICIPANTS: Men (n=636) and women (n=899) from the Rancho Bernardo study (median age 74) were assessed between 1988 and 1992 for cognitive function using the Mini-Mental State Examination (MMSE), Verbal Fluency (VF) test, and Trail-Making Test Part B (Trails B). Blood samples were obtained at the same time for IGF-1 and IGFBP-1 levels. The association between biomarkers and cognitive function tests was assessed by dichotomizing tests at the clinically relevant cutoff using logistic regression and according to tertiles and continuous IGF-1 and IGFBP-1 levels using multivariate linear regression analyses. RESULTS: The mean MMSE, VF and Trails B scores indicated better cognitive function with higher IGF-1 tertile. Multivariate analyses showed that VF and MMSE were each significantly associated with IGF-1 in a dose-response manner for men (P for trend=.001), but no cognitive function tests were related to IGF-1 in women. For men, the highest IGFBP-1 tertile was inversely and significantly different from the lowest tertile for the MMSE test only (P for trend=.02). CONCLUSION: IGF-1 was independently and positively related to MMSE and VF in men, and IGFBP-1 was inversely associated with MMSE in men. Sex differences in the association should be further investigated.
OBJECTIVES: To assess the association between insulinlike growth factor (IGF)-1 and IGF binding protein (IGFBP)-1 with three cognitive function tests in a healthy elderly population. DESIGN: Cross-sectional analyses from the Rancho Bernardo Cohort Study. SETTING: Southern California community of Rancho Bernardo. PARTICIPANTS: Men (n=636) and women (n=899) from the Rancho Bernardo study (median age 74) were assessed between 1988 and 1992 for cognitive function using the Mini-Mental State Examination (MMSE), Verbal Fluency (VF) test, and Trail-Making Test Part B (Trails B). Blood samples were obtained at the same time for IGF-1 and IGFBP-1 levels. The association between biomarkers and cognitive function tests was assessed by dichotomizing tests at the clinically relevant cutoff using logistic regression and according to tertiles and continuous IGF-1 and IGFBP-1 levels using multivariate linear regression analyses. RESULTS: The mean MMSE, VF and Trails B scores indicated better cognitive function with higher IGF-1 tertile. Multivariate analyses showed that VF and MMSE were each significantly associated with IGF-1 in a dose-response manner for men (P for trend=.001), but no cognitive function tests were related to IGF-1 in women. For men, the highest IGFBP-1 tertile was inversely and significantly different from the lowest tertile for the MMSE test only (P for trend=.02). CONCLUSION:IGF-1 was independently and positively related to MMSE and VF in men, and IGFBP-1 was inversely associated with MMSE in men. Sex differences in the association should be further investigated.
Authors: A L Friedlander; G E Butterfield; S Moynihan; J Grillo; M Pollack; L Holloway; L Friedman; J Yesavage; D Matthias; S Lee; R Marcus; A R Hoffman Journal: J Clin Endocrinol Metab Date: 2001-04 Impact factor: 5.958
Authors: P S van Dam; A Aleman; W R de Vries; J B Deijen; E A van der Veen; E H de Haan; H P Koppeschaar Journal: Growth Horm IGF Res Date: 2000-04 Impact factor: 2.372
Authors: J Guan; A J Gunn; E S Sirimanne; J Tuffin; M I Gunning; R Clark; P D Gluckman Journal: J Cereb Blood Flow Metab Date: 2000-03 Impact factor: 6.200
Authors: Arny A Ferrando; Melinda Sheffield-Moore; Catherine W Yeckel; Charles Gilkison; Jie Jiang; Alison Achacosa; Steven A Lieberman; Kevin Tipton; Robert R Wolfe; Randall J Urban Journal: Am J Physiol Endocrinol Metab Date: 2002-03 Impact factor: 4.310
Authors: Manthos G Giannoulis; Finbarr C Martin; K Sreekumaran Nair; A Margot Umpleby; Peter Sonksen Journal: Endocr Rev Date: 2012-03-20 Impact factor: 19.871
Authors: T Doi; H Makizako; K Tsutsumimoto; R Hotta; S Nakakubo; K Makino; T Suzuki; H Shimada Journal: J Nutr Health Aging Date: 2018 Impact factor: 4.075
Authors: Andrew J Westwood; Alexa Beiser; Charles Decarli; Tamara B Harris; Tai C Chen; Xue-Mei He; Ronenn Roubenoff; Aleksandra Pikula; Rhoda Au; Lewis E Braverman; Philip A Wolf; Ramachandran S Vasan; Sudha Seshadri Journal: Neurology Date: 2014-04-04 Impact factor: 9.910
Authors: Sandra Sánchez-Sarasúa; Alberto Ribes-Navarro; María Teresa Beltrán-Bretones; Ana María Sánchez-Pérez Journal: Brain Struct Funct Date: 2020-11-27 Impact factor: 3.270